Johnson & Johnson coronavirus vaccine trial paused after participant’s ‘unexplained illness’

Read More<p>Pause affects all the company’s trials, in which about 60,000 adults from across the globe were expected to participate</p><p>Pause affects all the company’s trials, in which about 60,000 adults from across the globe were expected to participate</p>